Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

By Polee M.B.   Verweij J.   Siersema P.D.   Tilanus H.W.   Splinter T.A.W.   Stoter G.   Van der Gaast A.  

European Journal of Cancer, Vol. 38, Iss. 11, 2002-07 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite

A Dose Escalating Study of Oxaliplatin and High Dose Weekly Leucovorin and 5-Fluorouracil in Patients with Advanced Solid Tumors

By Souglakos John   Kakolyris Stylianos   Vardakis Nikolaos   Androulakis Nikolaos   Mavroudis Dimitrios   Vamvakas Lambos   Kouroussis Charalambos   Agelaki Sophia   Saridaki Zacharenia   Georgoulias Vassilis  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 505-510

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors

By Saif Muhammad   Sellers Sandra   Li Mao   Wang Wei   Cusimano Linda   Wang Hui   Zhang Ruiwen  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 871-882

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer

By Hara Takuo   Omura Kenji   Hirano Makoto   Asada Yasuyuki   Munemoto Yoshinori   Sakamoto Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 631-636

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

By Jeung Hei-Cheul   Rha Sun   Noh Sung   Roh Jae   Chung Hyun  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite